CymaBay Therapeutics’ $4.3 Billion Acquisition by Gilead Sciences
February 12, 2024
On February 12, 2024, CymaBay Therapeutics (“CymaBay”) and Gilead Sciences, Inc. (“Gilead”) announced a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of primary biliary cholangitis, complements Gilead’s existing liver portfolio and aligns with its longstanding commitment to bringing transformational medicines to patients. Cravath is representing CymaBay in connection with the transaction.
The Cravath team is led by partners Richard Hall and Matthew L. Ploszek and includes associates Richard E. Schwartz and Temiloluwa A. Dele-Dare, and foreign associate attorney Roosa Väre on M&A matters; partner Jonathan J. Katz, senior attorney Arian Mossanenzadeh, and associates Brendon J. Rivard and Caroline Wyatt on executive compensation and benefits matters; partner J. Leonard Teti II and associates Sonia Katharani‑Khan and Chloe Amarilla on tax matters; partner Sasha Rosenthal‑Larrea and associate David M. Ungar on intellectual property matters; partner Matthew Morreale on environmental matters; partner Jesse M. Weiss on antitrust matters; and senior attorney Joyce Law and practice area attorney Brian Budnick on real estate matters. Gabriela Flores‑Romo also worked on M&A matters, and Kenya Rowser also worked on intellectual property matters.
Related Practices & Industries
People
- Photo
-
-
LL.M., 1988, Harvard Law School
-
LL.B., 1986, University of Melbournewith Honors
-
B.Com., 1984, University of Melbournewith Honors
- New York
Education
Admitted In
- Photo
-
-
J.D., 2014, University of Pennsylvania Law Schoolcum laude
-
M.B.A., 2014, The Wharton School of the University of PennsylvaniaGraduation with Honors
-
B.A., 2007, University of Notre DamePhi Beta Kappa, summa cum laude
- New York
Education
Admitted In
- Photo
-
-
LL.M., 2013, New York University School of Law
-
J.D., 2007, Benjamin N. Cardozo School of LawOrder of the Coif, Dean's Distinguished Scholar, summa cum laude
-
B.S., 2003, Cornell University
- New York
Education
Admitted In
- Photo
-
-
J.D., 2005, University of Virginia School of LawOrder of the Coif
-
A.B., 1999, Princeton Universitywith Honors
- New York
Education
Admitted In
- Photo
-
-
J.D., 2010, Columbia Law SchoolHarlan Fiske Stone Scholar
-
A.B., 2007, Brown University
- New York
Education
Admitted In
- Photo
-
-
J.D., 1997, Columbia Law SchoolHarlan Fiske Stone Scholar
-
M.S., 1994, University of Pennsylvania
-
B.A., 1990, University of Pennsylvania
-
B.A.S., 1990, University of Pennsylvania
- New York
Education
Admitted In
- Photo
-
-
J.D., 2008, Georgetown University Law Centermagna cum laude
-
B.A., 2003, University of Maryland
- New York
Education
Admitted In
- Photo
-
-
J.D., 2013, University of Virginia School of Law
-
B.A., 2008, University of Washingtonwith Distinction, Phi Beta Kappa, magna cum laude
- New York
Education
Admitted In
-
J.D., 1997, Boston University School of Law
-
B.Comm., 1994, University of AlbertaDistinction
- New York
Education
Admitted In
- Photo
-
-
J.D., 2011, Benjamin N. Cardozo School of Lawcum laude
-
B.A., 2006, University of Virginia
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
November 13, 2024
Just Eat Takeaway.com’s Sale of Grubhub to Wonder
On November 13, 2024, Just Eat Takeaway.com N.V. (“Just Eat Takeaway.com”), one of the world’s leading global online food delivery companies, announced that it has entered into a definitive agreement to sell Grubhub Inc. (“Grubhub”) to Wonder Group, Inc. (“Wonder”) for an enterprise value of $650 million. Grubhub will be transferred with its $500 million of senior notes. Cravath is representing Just Eat Takeaway.com in connection with the transaction.
Deals & Cases
October 25, 2024
L&G’s Investment in Taurus Investment Holdings
On October 25, 2024, Legal & General (“L&G”), one of the U.K.’s leading financial services groups and a major global investor, announced its strategic investment in Taurus Investment Holdings, LLC (“Taurus”), a Boston‑based, global real estate private equity firm, alongside an initial commitment of up to $200 million in seed capital to multifamily real estate. Cravath is representing L&G in connection with the transaction.
Deals & Cases
July 16, 2024
Atalaya Capital Management’s Sale of its Business to Blue Owl Capital
On July 16, 2024, Atalaya Capital Management LP (“Atalaya Capital Management”), a privately‑held alternative credit manager, and Blue Owl Capital Inc. (“Blue Owl Capital”), an alternative asset manager, announced that they have entered into a definitive agreement for Blue Owl Capital to acquire the business of Atalaya Capital Management for $450 million. The closing purchase price of $450 million is comprised of $350 million of Blue Owl equity and $100 million of cash. In addition, there is potential for up to $350 million of earnout consideration in the form of equity, subject to certain adjustments and achievement of future revenue targets. Cravath is representing Atalaya Capital Management in connection with the transaction.
Deals & Cases
May 28, 2024
UScellular’s $4.4 Billion Sale of Wireless Operations and Select Spectrum Assets to T‑Mobile
On May 28, 2024, United States Cellular Corporation (“UScellular”) announced that it has entered into a definitive agreement to sell its wireless operations and select spectrum assets to T‑Mobile for a purchase price of $4.4 billion, including a combination of cash and up to approximately $2 billion of assumed debt. Under the terms of the agreement, T‑Mobile will acquire UScellular’s wireless operations and approximately 30% of its spectrum assets across several spectrum bands. In addition, T‑Mobile will enter into a new master license agreement with UScellular on more than 2,000 towers. The agreement follows a thorough strategic review process announced in August 2023 and has been unanimously recommended by the independent directors of UScellular and unanimously approved by the Board of Directors of UScellular. Cravath is representing the independent directors of UScellular in connection with the transaction.
